JU Gutterman

1.1k total citations
23 papers, 876 citations indexed

About

JU Gutterman is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, JU Gutterman has authored 23 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in JU Gutterman's work include Chronic Myeloid Leukemia Treatments (10 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). JU Gutterman is often cited by papers focused on Chronic Myeloid Leukemia Treatments (10 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). JU Gutterman collaborates with scholars based in United States. JU Gutterman's co-authors include Moshe Talpaz, KB McCredie, Saroj Vadhan‐Raj, A LeMaistre, HE Broxmeyer, Razelle Kurzrock, S Buescher, Ernest C. Borden, Loretta M. Itri and B Barlogie and has published in prestigious journals such as Blood, Experimental Biology and Medicine and Pathology.

In The Last Decade

JU Gutterman

23 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JU Gutterman United States 11 581 337 243 207 152 23 876
I Murohashi Japan 16 497 0.9× 131 0.4× 187 0.8× 152 0.7× 285 1.9× 63 806
R. Fischer Germany 15 365 0.6× 341 1.0× 136 0.6× 104 0.5× 166 1.1× 41 741
R. D. Brunning United States 12 252 0.4× 194 0.6× 84 0.3× 229 1.1× 103 0.7× 16 625
Gianluigi Castoldi Italy 19 483 0.8× 278 0.8× 252 1.0× 330 1.6× 237 1.6× 36 957
S Eridani Italy 16 617 1.1× 477 1.4× 102 0.4× 129 0.6× 210 1.4× 71 1.0k
Angeline Van Orshoven Belgium 15 488 0.8× 291 0.9× 75 0.3× 111 0.5× 183 1.2× 29 735
DC Young United States 10 531 0.9× 118 0.4× 232 1.0× 375 1.8× 295 1.9× 11 981
R Neuwírtová Czechia 16 653 1.1× 302 0.9× 141 0.6× 123 0.6× 364 2.4× 61 946
A. Louwagie Belgium 24 842 1.4× 679 2.0× 198 0.8× 235 1.1× 354 2.3× 67 1.4k
JR Testa United States 15 1.0k 1.8× 238 0.7× 104 0.4× 122 0.6× 541 3.6× 27 1.3k

Countries citing papers authored by JU Gutterman

Since Specialization
Citations

This map shows the geographic impact of JU Gutterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JU Gutterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JU Gutterman more than expected).

Fields of papers citing papers by JU Gutterman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JU Gutterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JU Gutterman. The network helps show where JU Gutterman may publish in the future.

Co-authorship network of co-authors of JU Gutterman

This figure shows the co-authorship network connecting the top 25 collaborators of JU Gutterman. A scholar is included among the top collaborators of JU Gutterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JU Gutterman. JU Gutterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Estrov, Zeev, Razelle Kurzrock, E Estey, et al.. (1992). Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Blood. 79(8). 1938–1945. 6 indexed citations
8.
Vadhan‐Raj, Saroj, et al.. (1990). Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromes [letter]. Blood. 75(8). 1749–1750. 9 indexed citations
11.
12.
Gutterman, JU, et al.. (1987). Expression of c-fos, c-myb, and c-myc in human monocytes: correlation with monocytic differentiation. Blood. 69(5). 1542–1545. 4 indexed citations
13.
Gutterman, JU, et al.. (1987). Expression of c-fos, c-myb, and c-myc in human monocytes: correlation with monocytic differentiation. Blood. 69(5). 1542–1545. 28 indexed citations
14.
Kurzrock, Razelle, et al.. (1987). Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia. Blood. 70(1). 233–236. 37 indexed citations
15.
Barlogie, B, et al.. (1986). Treatment of multiple myeloma with recombinant alpha-interferon. Blood. 67(2). 275–278. 95 indexed citations
16.
Barlogie, B, et al.. (1986). Treatment of multiple myeloma with recombinant alpha-interferon. Blood. 67(2). 275–278. 2 indexed citations
17.
Talpaz, Moshe, et al.. (1983). Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. Blood. 62(3). 689–692. 12 indexed citations
18.
Pihl, E., Birger Jansson, M. Schwartz, et al.. (1982). Germinal centre hyperplasia: An unfavourable immune response in recurrent malignant melanoma. Pathology. 14(1). 13–16. 2 indexed citations
19.
Gutterman, JU, et al.. (1979). Human leukocyte interferon preparation blocks granulopoietic differentiation. Blood. 54(6). 1423–1427. 71 indexed citations
20.
Peters, Leona C., et al.. (1974). Modulation of the Immune Response of Guinea Pigs by Repeated BCG Scarification. Experimental Biology and Medicine. 147(2). 344–349. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026